CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L603. A total of 24 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $81,581 | -39.8% | 230,000 | 0.0% | 0.00% | – |
| Q2 2023 | $135,493 | +3.3% | 230,000 | 0.0% | 0.00% | – |
| Q1 2023 | $131,215 | -14.5% | 230,000 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $153,410 | -54.3% | 230,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $336,000 | +35.5% | 230,000 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $248,000 | -64.7% | 230,000 | 0.0% | 0.00% | -66.7% |
| Q1 2022 | $702,000 | -21.6% | 230,000 | 0.0% | 0.00% | -25.0% |
| Q4 2021 | $895,000 | -26.2% | 230,000 | 0.0% | 0.00% | -20.0% |
| Q3 2021 | $1,212,000 | -11.0% | 230,000 | 0.0% | 0.01% | -16.7% |
| Q2 2021 | $1,362,000 | -16.7% | 230,000 | 0.0% | 0.01% | -25.0% |
| Q1 2021 | $1,635,000 | – | 230,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 250,000 | $365,000 | 0.05% |
| McIlrath & Eck, LLC | 26,342 | $38,000 | 0.01% |
| Schonfeld Strategic Advisors LLC | 615,200 | $898,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 367,477 | $535,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 12,800 | $19,000 | 0.00% |
| Point72 Asset Management, L.P. | 230,000 | $336,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 61,816 | $90,000 | 0.00% |
| STATE STREET CORP | 10,510 | $15,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 195,445 | $285,000 | 0.00% |
| MORGAN STANLEY | 1,200 | $2,000 | 0.00% |